Evidence map›Paper›PMID 19230972›Full record

ArticleLeukemia research2009

Inhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1.

Kimiko Ishiguro, Anna M Rice, Kevin P Rice, Alan C Sartorelli

Abstract read
In one paragraph

Article in Leukemia research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kimiko IshiguroDepartment of Pharmacology and Developmental Therapeutics Program, Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Anna M Rice
Kevin P Rice
Alan C Sartorelli
Yale Cancer Center · USColby College · USYale University · US

Funding

TERMINAL DIFFERNTIATION AS A THERAPEUTIC APPROACHR01CA002817 · NCI · YALE UNIVERSITY · PI SARTORELLI, ALAN CLAYTON · 1985 to 2001
$391k
NCI NIH HHS R01 CA002817
6 · The paper itself

Abstract

All-trans retinoic acid (ATRA) induces granulocytic maturation of WEHI-3B D+ leukemia cells and LiCl enhances this maturation, while WEHI-3B D- cells are non-responsive to ATRA. Transfection of SCL, expressed in D- but absent in D+ cells, into D+ cells, caused resistance to ATRA, while transfection of GATA-1 into D+ cells produced resistance to the combination of ATRA and LiCl. SCL expression in D+ cells did not induce the expression of c-Kit, a putative target gene for SCL. LiCl, known to inhibit some kinases by displacing Mg2+, did not affect tyrosine kinase activity of the cytoplasmic domain of c-Kit.

Indexed as

AnimalsBase SequenceBenzamidesCell DifferentiationCell Line, TumorDNA PrimersGATA1 Transcription FactorGranulocytesImatinib MesylateLithium ChlorideMiceOncogene Proteins, FusionPiperazinesPlasmidsProtein-Tyrosine KinasesPyrimidinesBenzamidesDNA PrimersGata1 protein, mouseGATA1 Transcription FactorImatinib MesylateLithium ChlorideOncogene Proteins, FusionPiperazinesProtein-Tyrosine KinasesPyrimidinesRNA, MessengerSIL protein, mouseTretinoin

Identifiers

PMID19230972
PMCPMC2780339
OpenAlexW2074934299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.